| 2024-02-13 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Scientific Officer | 1,432 0.0015% | $132.94 | $190,371 | +2.66% | |
| 2024-01-31 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Scientific Officer | 126 0.0001% | $141.94 | $17,884 | -1.96% | |
| 2023-11-29 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Scientific Officer | 2,331 0.0024% | $113.57 | $264,733 | +19.29% | |
| 2023-08-21 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Scientific Officer | 3,198 0.0032% | $107.37 | $343,368 | +22.37% | |
| 2023-02-07 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Scientific Officer | 4,508 0.0046% | $102.30 | $461,166 | +0.86% | |
| 2023-01-31 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Scientific Officer | 126 0.0001% | $108.48 | $13,668 | -5.7% | |
| 2022-11-29 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Scientific Officer | 2,331 0.0024% | $121.90 | $284,160 | -14.07% |